Rice Hall James & Associates’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $11.2M | Sell |
|
|||||
|
2025
Q2 | $8.2M | Buy |
|
|||||
|
2025
Q1 | $4.99M | Sell |
|
|||||
|
2024
Q4 | $2.81M | Sell |
|
|||||
|
2024
Q3 | $4.75M | Buy |
|
|||||
|
2024
Q2 | $4.96M | Buy |
|
|||||
|
2024
Q1 | $4.88M | Buy |
|
|||||
|
2023
Q4 | $4.9M | Sell |
|
|||||
|
2023
Q3 | $3.01M | Sell |
|
|||||
|
2023
Q2 | $5.62M | Buy |
|
|||||
|
2023
Q1 | $5.31M | Buy |
|
|||||
|
2022
Q4 | $4.57M | Buy |
|
|||||
|
2022
Q3 | $2.94M | Buy |
|
|||||
|
2022
Q2 | $4.9M | Buy |
|
|||||
|
2022
Q1 | $1.51M | Buy |
|
|||||
|
2021
Q4 | $2.42M | Sell |
|
|||||
|
2021
Q3 | $3.94M | Buy |
|
|||||
|
2021
Q2 | $2.79M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1.22M | Buy |
|